Dermatology · Scottsdale, AZ
NPI
1659589638
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13400 E Shea Blvd
Scottsdale, AZ, 85259
Phone (480) 301-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
685 services
Medicare patients, 2024
275
Average age 71
Drug cost, 2024
$2.0M
1,242 prescriptions
Company payments, 2025
$56
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rashmi D Unwala was code 17003 (destruction skin lesion), 120 times for 30 patients. In total Rashmi D Unwala billed 685 services in 27 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Facility | 120 | 30 | $1.49 | $179 |
| 99213 Office E&M - Established | Facility | 118 | 107 | $45.64 | $5,386 |
| 99214 Office E&M - Established | Facility | 69 | 58 | $68.89 | $4,754 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 58 | 51 | $12.49 | $724 |
| 17000 Destruction Skin Lesion | Facility | 42 | 39 | $38.04 | $1,598 |
| 99204 Office E&M - New | Facility | 32 | 32 | $88.82 | $2,842 |
| 99214 Office E&M - Established | Office | 31 | 25 | $88.81 | $2,753 |
| 99203 Office E&M - New | Facility | 27 | 27 | $48.81 | $1,318 |
| 11104 Skin Biopsy | Facility | 27 | 25 | $28.63 | $773 |
| 11102 Skin Biopsy | Facility | 24 | 24 | $22.44 | $539 |
| 99232 Hospital E&M - Subsequent | Facility | 23 | 18 | $59.41 | $1,367 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 20 | $12.49 | $275 |
| 17110 Destruction Skin Lesion | Facility | 16 | 15 | $50.96 | $815 |
| 99213 Office E&M - Established | Office | 15 | 15 | $56.13 | $842 |
By year: 2022 $27K for 728 services; 2023 $24K for 700 services; 2024 $27K for 685 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rashmi D Unwala prescribed most often to Medicare patients was Ketoconazole, with 102 prescriptions and refills. In total Rashmi D Unwala wrote 1,242 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 102 | 123 | 36 | $1,699 |
| Triamcinolone Acetonide Generic | 101 | 111 | 60 | $2,008 |
| Cosentyx Unoready Pen Secukinumab | 84 | 84 | Under 11 | $927K |
| Clobetasol Propionate Generic | 70 | 76 | 38 | $4,168 |
| Clindamycin Phosphate Generic | 43 | 47 | 16 | $2,002 |
| Doxycycline Hyclate Generic | 43 | 58 | 23 | $1,349 |
| Hydrocortisone Generic | 42 | 55 | 20 | $744 |
| Metronidazole Generic | 40 | 41 | 13 | $1,813 |
| Minoxidil Generic | 36 | 108 | 18 | $487 |
| Fluocinonide Generic | 36 | 43 | 17 | $1,712 |
| Tacrolimus Generic | 35 | 45 | 12 | $7,607 |
| Dupixent Pen Dupilumab | 30 | 30 | Under 11 | $109K |
| Hydroxychloroquine Sulfate Generic | 28 | 67 | 11 | $692 |
| Prednisone Generic | 26 | 32 | 17 | $175 |
| Methotrexate Methotrexate Sodium | 24 | 47 | Under 11 | $430 |
Brand drugs: 285 claims; generic drugs: 957 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rashmi D Unwala $56 ($56 in general payments such as food, travel and fees) from 3 companies. The largest payer was Galderma Laboratories, L.P. with $21.93.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.